Logo image of MSPR

MSP RECOVERY INC (MSPR) Stock Fundamental Analysis

NASDAQ:MSPR - Nasdaq - US5537453087 - Common Stock - Currency: USD

2.07  +0.32 (+18.29%)

After market: 2.06 -0.01 (-0.48%)

Fundamental Rating

2

MSPR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 106 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of MSPR have multiple concerns. MSPR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MSPR has reported negative net income.
In the past year MSPR has reported a negative cash flow from operations.
In the past 5 years MSPR always reported negative net income.
In the past 5 years MSPR reported 4 times negative operating cash flow.
MSPR Yearly Net Income VS EBIT VS OCF VS FCFMSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

MSPR has a Return On Assets of -3.49%. This is in the lower half of the industry: MSPR underperforms 61.32% of its industry peers.
The Return On Equity of MSPR (-32.40%) is worse than 68.87% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROIC N/A
ROA(3y)-11.27%
ROA(5y)-34.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSPR Yearly ROA, ROE, ROICMSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 -50 -100

1.3 Margins

With an excellent Gross Margin value of 66.22%, MSPR belongs to the best of the industry, outperforming 87.74% of the companies in the same industry.
MSPR's Gross Margin has declined in the last couple of years.
MSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
MSPR Yearly Profit, Operating, Gross MarginsMSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

MSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MSPR has less shares outstanding
Compared to 1 year ago, MSPR has a worse debt to assets ratio.
MSPR Yearly Shares OutstandingMSPR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1B 2B 3B
MSPR Yearly Total Debt VS Total AssetsMSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

MSPR has an Altman-Z score of -1.22. This is a bad value and indicates that MSPR is not financially healthy and even has some risk of bankruptcy.
MSPR's Altman-Z score of -1.22 is on the low side compared to the rest of the industry. MSPR is outperformed by 83.02% of its industry peers.
MSPR has a Debt/Equity ratio of 2.54. This is a high value indicating a heavy dependency on external financing.
MSPR has a worse Debt to Equity ratio (2.54) than 78.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC4.08%
MSPR Yearly LT Debt VS Equity VS FCFMSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.01 indicates that MSPR may have some problems paying its short term obligations.
MSPR's Current ratio of 0.01 is on the low side compared to the rest of the industry. MSPR is outperformed by 94.34% of its industry peers.
A Quick Ratio of 0.01 indicates that MSPR may have some problems paying its short term obligations.
MSPR's Quick ratio of 0.01 is on the low side compared to the rest of the industry. MSPR is outperformed by 94.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
MSPR Yearly Current Assets VS Current LiabilitesMSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for MSPR have decreased strongly by -1533.49% in the last year.
MSPR shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.67%.
The Revenue for MSPR have been decreasing by -17.83% on average. This is quite bad
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.78%
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%

3.2 Future

Based on estimates for the next years, MSPR will show a very strong growth in Earnings Per Share. The EPS will grow by 181.53% on average per year.
Based on estimates for the next years, MSPR will show a very strong growth in Revenue. The Revenue will grow by 163.31% on average per year.
EPS Next Y264.17%
EPS Next 2Y198.76%
EPS Next 3Y181.53%
EPS Next 5YN/A
Revenue Next Year203.87%
Revenue Next 2Y200.77%
Revenue Next 3Y163.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MSPR Yearly Revenue VS EstimatesMSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B
MSPR Yearly EPS VS EstimatesMSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 200 400 600 800 1K

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 0.03, which indicates a rather cheap valuation of MSPR.
MSPR's Price/Forward Earnings ratio is rather cheap when compared to the industry. MSPR is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MSPR to the average of the S&P500 Index (21.08), we can say MSPR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.03
MSPR Price Earnings VS Forward Price EarningsMSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MSPR Per share dataMSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MSPR's earnings are expected to grow with 181.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y198.76%
EPS Next 3Y181.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MSPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MSP RECOVERY INC

NASDAQ:MSPR (4/17/2025, 8:00:00 PM)

After market: 2.06 -0.01 (-0.48%)

2.07

+0.32 (+18.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)05-14 2025-05-14
Inst Owners18.54%
Inst Owner Change0%
Ins Owners9.61%
Ins Owner Change0%
Market Cap17.06M
Analysts82.86
Price TargetN/A
Short Float %7.84%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.03
P/S 1.37
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-101.6
EYN/A
EPS(NY)76.47
Fwd EY3694.44%
FCF(TTM)-4.08
FCFYN/A
OCF(TTM)-3.72
OCFYN/A
SpS1.52
BVpS42.42
TBVpS-349.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.22%
FCFM N/A
ROA(3y)-11.27%
ROA(5y)-34.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.53%
Cap/Sales 23.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.22
F-Score3
WACC4.08%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.78%
EPS Next Y264.17%
EPS Next 2Y198.76%
EPS Next 3Y181.53%
EPS Next 5YN/A
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%
Revenue Next Year203.87%
Revenue Next 2Y200.77%
Revenue Next 3Y163.31%
Revenue Next 5YN/A
EBIT growth 1Y12.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.17%
OCF growth 3YN/A
OCF growth 5YN/A